InvestorsHub Logo
Followers 26
Posts 2972
Boards Moderated 0
Alias Born 02/21/2007

Re: BIOCHEMUP post# 1482

Sunday, 04/12/2020 4:00:45 PM

Sunday, April 12, 2020 4:00:45 PM

Post# of 27113
It's the risk reward factor. You've got a GSA contract holder that submits to FDA audits, producing a kit that can save lives. The validation of the company's history gives them a low risk and extremely high reward. That's why a lot of us here have been touting the company. This is huge for governments that plan on getting ahead of the game before FDA approval hits. In reality it isn't about the stock it is about saving lives.